Treatment of Von Hippel-Lindau (VHL)-Related Hemangioblastoma With PTK787/ZK 222584
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether PTK787/ZK 222584 is effective in treating
hemangioblastoma of the brain and/or retina in patients with von Hippel-Lindau disease. The
study will also assess safety and tolerability of PTK787/ZK 222584, and changes in markers of
angiogenesis (new blood vessel growth).